Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 2551, April 15, 2008. doi: 10.1158/0008-5472.CAN-07-2095
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bagchi, A.
Right arrow Articles by Mills, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagchi, A.
Right arrow Articles by Mills, A. A.
Related Collections
Right arrow Cellular Pathobiology
Right arrow Cellular Pathobiology: Cancer Genes and Genomics

Reviews

The Quest for the 1p36 Tumor Suppressor

Anindya Bagchi and Alea A. Mills

Cold Spring Harbor Laboratory, Cold Spring Harbor, New York

Requests for reprints: Alea A. Mills, Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724. Phone: 516-367-6910; E-mail: mills{at}cshl.edu.

Key Words: 1p36CHD5 • chromosome engineering • p53 • Ink4/Arf

Genomic analyses of late-stage human cancers have uncovered deletions encompassing 1p36, thereby providing an extensive body of literature supporting the idea that a potent tumor suppressor resides in this interval. Although several genes have been proposed as 1p36 candidate tumor suppressors, convincing evidence that their encoded products protect from cancer has been scanty. A recent functional study identified chromodomain helicase DNA-binding protein 5 (CHD5) as a novel tumor suppressor mapping to 1p36. Here, we discuss evidence supporting the tumor-suppressive role of CHD5. Together, these findings suggest that strategies designed to enhance CHD5 activity could provide novel approaches for treating a broad range of human malignancies. [Cancer Res 2008;68(8):2551–6]




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Pigazzi, E. Manara, E. Baron, and G. Basso
miR-34b Targets Cyclic AMP-Responsive Element Binding Protein in Acute Myeloid Leukemia
Cancer Res., March 15, 2009; 69(6): 2471 - 2478.
[Abstract] [Full Text] [PDF]


Home page
CRO ContentHome page
G. C. Prendergast
Risk Factors for Cancer: From Cell to Microenvironment
Cancer Reviews Online Content, May 1, 2008; 2008(5): 9 - 9.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.